XML 31 R17.htm IDEA: XBRL DOCUMENT v3.22.4
Note 10 - Warrants
3 Months Ended
Dec. 31, 2022
Notes to Financial Statements  
Warrants Disclosure [Text Block]

NOTE 10 - WARRANTS

 

Transactions involving the Company equity-classified warrants for the three months ended December 31, 2022 and 2021 are summarized as follows:

 

          

Weighted-average

     
          

remaining

  

Aggregate

 
      

Weighted-average

  

contractual term

  

intrinsic value

 
  

Number of shares

  

exercise price

  

(in years)

  

(in thousands)

 

Outstanding at September 30, 2022

  589,917  $4.68   2.30  $- 

Granted

  -   -       - 

Exercised

  -   -         

Forfeited

  (100,000)  7.50         

Outstanding at December 31, 2022

  489,917   4.10   2.79   - 
                 

Exercisable at December 31, 2022

  489,917  $4.10   -  $- 

 

During the three month period ended December 31, 2022, 100,000 warrants expired and as a result were forfeited.

 

The following table summarizes outstanding common stock purchase warrants as of December 31, 2022:

 

      

Weighted-average

  
  

Number of shares

  

exercise price

 

Expiration

Exercisable at $4.375 per share

  51,429   4.375 

September 2023

Exercisable at $7.50 per share

  60,000   7.50 

May 2024

Exercisable at $3.9125 per share

  47,822   3.9125 

October 2024

Exercisable at $1.25 per share

  36,682   1.25 

January 2025

Exercisable at $3.74 per share

  150,502   3.74 

December 2025

Exercisable at $3.75 per share

  143,482   3.75 

June 2026

   489,917  $4.10